Finally, the applicant stated that, under the regulation at 419.66(a), CMS makes a pass-through payment for a medical device that meets the requirements in paragraph (b) of that section and that is described by a category of devices established by CMS under the criteria in paragraph (c) of that section, and that, further, according to 419.66(g), the pass-through period begins on the first date on which pass-through payment is made
The prescribing information notes that gastrointestinal adverse effects are the most common reasons for treatment discontinuation
Synaptic pruning by microglia is necessary for normal brain development
doi: 10.1038/ejcn.2012.160 35 FaulFErdfelderELangAGBuchnerA
MDA content was calculated by correcting for compounds, other than MDA, that absorb at 532 and 600 nm, by subtracting the absorbance at 532 and 600 nm of a solution containing plant extract incubated without TBA from an identical solution containing TBA
Side effects that seemed challenging at week 9 have typically faded by week 17
